BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8433095)

  • 1. Post-ischemic brain tissue alkalosis suppressed by U74006F.
    Vande Linde AM; Chopp M; Lee SA; Schultz LR; Welch KM
    J Neurol Sci; 1993 Jan; 114(1):36-9. PubMed ID: 8433095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 21-aminosteroid lipid peroxidation inhibitor, U74006F, in the rat middle cerebral artery occlusion model.
    Umemura K; Wada K; Uematsu T; Mizuno A; Nakashima M
    Eur J Pharmacol; 1994 Jan; 251(1):69-74. PubMed ID: 8137871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic neocortical protection with U74006F--a dose-response curve.
    Sutherland G; Haas N; Peeling J
    Neurosci Lett; 1993 Jan; 149(2):123-5. PubMed ID: 8474682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of renal reperfusion injury in rats by the 21-aminosteroid U74006F.
    Stanley JJ; Goldblum JR; Frank TS; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1993 Apr; 17(4):685-9. PubMed ID: 8464086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of U74006F on forebrain ischemia in rats.
    Lesiuk H; Sutherland G; Peeling J; Butler K; Saunders J
    Stroke; 1991 Jul; 22(7):896-901. PubMed ID: 1853409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils.
    Hall ED; Pazara KE; Braughler JM
    Stroke; 1988 Aug; 19(8):997-1002. PubMed ID: 3400111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effects of tirilated mesylate (U74006F) on ischemic and reperfusion-induced cochlear damage.
    Seidman MD; Quirk WS
    Otolaryngol Head Neck Surg; 1991 Oct; 105(4):511-6. PubMed ID: 1762789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of the lipid peroxidation inhibitor, U74006F, to prevent postischemic selective neuronal injury.
    Buchan AM; Bruederlin B; Heinicke E; Li H
    J Cereb Blood Flow Metab; 1992 Mar; 12(2):250-6. PubMed ID: 1548297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of the lazaroid U74006F in cold ischemia-reperfusion injury of the liver.
    Cosenza CA; Cramer DV; Cunneen SA; Tuso PJ; Wang HK; Makowka L
    Hepatology; 1994 Feb; 19(2):418-25. PubMed ID: 8294099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel 21-aminosteroid U74006F attenuates cerebral edema and improves survival after brain injury in the rat.
    McIntosh TK; Thomas M; Smith D; Banbury M
    J Neurotrauma; 1992; 9(1):33-46. PubMed ID: 1619674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of the lipid peroxidation inhibitor U74006F to improve neurological outcome after transient forebrain ischemia in the rat.
    Beck T; Bielenberg GW
    Brain Res; 1990 Nov; 532(1-2):336-8. PubMed ID: 2282527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of lipid peroxidation does not prevent oxidant-induced myocardial contractile dysfunction.
    Kong Y; Lesnefsky EJ; Ye J; Horwitz LD
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2371-7. PubMed ID: 7810737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats.
    Hall ED
    J Neurosurg; 1988 Mar; 68(3):462-5. PubMed ID: 3343617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion.
    Carrea FP; Lesnefsky EJ; Kaiser DG; Horwitz LD
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):230-5. PubMed ID: 1381014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of hemorrhagic shock by the non-glucocorticoid 21-aminosteroid U74006F.
    Hall ED; Yonkers PA; McCall JM
    Eur J Pharmacol; 1988 Mar; 147(2):299-303. PubMed ID: 3366180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarct size in a canine model of myocardial ischemia reperfusion.
    Ovize M; de Lorgeril M; Ovize A; Ciavatti M; Delaye J; Renaud S
    Am Heart J; 1991 Sep; 122(3 Pt 1):681-9. PubMed ID: 1877444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs.
    Perkins WJ; Milde LN; Milde JH; Michenfelder JD
    Stroke; 1991 Jul; 22(7):902-9. PubMed ID: 1853410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of arachidonic acid-induced vasogenic brain edema by the non-glucocorticoid 21-aminosteroid U74006F.
    Hall ED; Travis MA
    Brain Res; 1988 Jun; 451(1-2):350-2. PubMed ID: 3150818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quicker metabolic recovery after forebrain ischemia in rats treated with the antioxidant U74006F.
    Haraldseth O; Grønås T; Unsgård G
    Stroke; 1991 Sep; 22(9):1188-92. PubMed ID: 1926263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: evidence for an in vivo antioxidant mechanism.
    Hall ED; Yonkers PA; Horan KL; Braughler JM
    J Neurotrauma; 1989; 6(3):169-76. PubMed ID: 2810381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.